• Montagu Acquires Tyber Medical 

    Montagu Private Equity announced on January 14 the acquisition of Tyber Medical for an undisclosed price. With this transaction, Montagu will merge Tyber Medical with its portfolio companies Intech and Resolve Surgical Technologies to create a new platform.   Tyber Medical is an orthopedic medical device manufacturer providing rapid... Read More »
  • Takara Bio USA Holdings Acquires Curio Bioscience 

    On January 15, Takara Bio USA Holdings Inc., a wholly owned subsidiary of Takara Bio Inc., announced that it acquired Curio Bioscience.   Curio Bioscience is a biotechnology company that is advancing a new generation of high-precision tools for the life sciences industry. The company has developed spatial biology capabilities to map the... Read More »
  • 2025 Kicks off With Several Big Biopharma Deals

    With the JP Morgan 43rd Annual Healthcare Conference underway in San Francisco this week, the Biotechnology and Pharmaceutical (Biopharma) sectors are seeing a flurry of activity. Many large-scale acquisitions and licensing agreements are being announced, setting the tone for an eventful year ahead in the industry. So far this year, 14 Biopharma... Read More »
  • In Motion Physical Therapy Joins PE-Backed Ivy Rehab

    Private equity-backed Ivy Rehab announced in January 2025 that it has partnered with In Motion Physical Therapy in Downingtown, Pennsylvania. Financial terms of the deal were not disclosed.  In Motion Physical Therapy is a provider of outpatient physical therapy in Pennsylvania. The company is led by a team of therapists specializing in... Read More »
  • West Physics Consulting Acquires Mid-South Medical Physics in Arkansas

    West Physics Consulting announced on January 13 that it has entered into a strategic partnership agreement with Mid-South Medical Physics. The partnership with Mid-South includes a multi-phase acquisition of Mid-South by West Physics, allowing Mid-South’s owner and President, Mr. Paul Beck, to gradually retire as West Physics supports him... Read More »
HCA Healthcare Emerging from Severe Staffing Headwinds

HCA Healthcare Emerging from Severe Staffing Headwinds

HCA Healthcare Inc (NYSE: HCA), a for-profit healthcare provider based in Nashville, Tennessee, reported $4.93 earnings per share for the quarter, beating the consensus estimate of $3.99 by a whopping $0.94. This increase is largely due to HCA Healthcare’s revenue growth, which was up 4.3% on a year over year basis from $14.9 billion in Q1:22 to $15.6 billion in Q1:23. The healthcare provider’s expenses rose from the first quarter of 2022, reaching $13.67 billion. Yet, despite the rising expenses, HCA Healthcare reported a $1.36 billion profit in the first quarter, an improvement from last year’s profit of $1.27 billion. However, this is a decrease from HCA’s $2.1 billion... Read More »
UnitedHealth Group Revenues up 15%, Focus on Value-Based Care Pays Off

UnitedHealth Group Revenues up 15%, Focus on Value-Based Care Pays Off

UnitedHealth Group Incorporated (NYSE: UNH), one of the largest health insurers in the United States, reported a positive performance in the first quarter of 2023, demonstrating balanced growth across its Optum and UnitedHealthcare business segments. The company’s revenue increased by 15% to $91.9 billion in Q1:23, and its adjusted earnings per share rose by 14% to $6.26 compared to the same period last year. Year-to-date, UnitedHealthcare also expanded its customer base, serving 1.2 million more people in the United States, with half of this growth coming from its commercial offerings. Additionally, the OptumHealth segment reported a significant increase in the number of patients... Read More »
Market Pressures Take Toll on Healthcare M&A in Q1:23

Market Pressures Take Toll on Healthcare M&A in Q1:23

Headwinds have finally slowed the healthcare M&A market. Throughout 2022, deal volume soared despite challenging market conditions, but activity in the first quarter of 2023 declined by 5% compared with the fourth quarter of 2022. The year-over-year drop was much more severe, falling 18%, or 531 deals compared with 647 deals. Factors such as growing labor costs, inflation and high-interest rates have stifled deal activity. Although we’re struggling to call any quarter with 500-plus deals slow, the opening three months of 2023 fell short of the 2022 quarterly average of 603 deals.    The swing in announced spending wasn’t nearly as dramatic. In the first quarter of 2023,... Read More »
Springtime Surge: 43 Healthcare M&A Deals Signal Busy Season Ahead

Springtime Surge: 43 Healthcare M&A Deals Signal Busy Season Ahead

The healthcare market has shown a significant increase in M&A activity since the start of April, with a total of 43 new deals recorded as of April 5th. The number of deals announced during the same period last year was lower at 38. So far, the announced deals point to a notable trend towards eHealth, with nine deals announced so far this month, making up approximately 21% of deals. By comparison, there were eight eHealth deals announced during the same period last year. Additionally, there has been an increase in Physician Medical Group deals, with 8 deals announced this year, compared to seven from last year. The specialties involved in these deals have also evolved, with a focus on... Read More »
Healthcare M&A Activity Will Post Another Drop in the First Quarter

Healthcare M&A Activity Will Post Another Drop in the First Quarter

With the first quarter of 2023 winding down, it is clear that healthcare M&A deal volume will continue to shrink. According to data captured in the LevinPro HC database on March 30, there were 502 deals recorded since the start of the year. This compares with 553 transactions posted in the fourth quarter of 2022, representing a 9% decline. This compares with totals of 612 and 598 in the third and second quarters of 2022, respectively. The current 2023 amount represents a 22% drop from the 647 posted in the first quarter of 2022.  The eHealth sector has shown dramatic declines in deal volume from the 120 recorded in the first quarter of 2022. Transactions plummeted to 48 in the fourth... Read More »
Bad Timing: Fed Raises Borrowing Costs During ACG NY Healthcare Conference

Bad Timing: Fed Raises Borrowing Costs During ACG NY Healthcare Conference

Some of the leading experts in the healthcare industry convened at the  ACG NY 15th Annual Healthcare Conference in New York City, and spirits were high amid the volatile environment surrounding M&A. No one brushed aside the headwinds facing the industry, such as inflation, labor shortages and costs, and rising interest rates during the March 22 event. Investors, analysts, lenders and advisors were confident they could close deals and grow businesses, but it’s going to require a more hands-on approach.  “You need to have a tailored thesis for each business,” said Andrew Colbert, senior managing director at Ziegler, during one of the panel discussions. “You can’t have a... Read More »